$12.07
0[0.00%]
At close: Apr 25
$12.07
0[0.00%]
After Hours: 4:00PM EDT
Boundless Bio
(NASDAQ:BOLD)Boundless Bio Stock (NASDAQ:BOLD), Analyst Ratings, Price Targets, Predictions
Boundless Bio Inc has a consensus price target of $23, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Leerink Partners, Guggenheim, and Piper Sandler on April 22, 2024. With an average price target of $23 between Leerink Partners, Guggenheim, and Piper Sandler, there's an implied 90.56% upside for Boundless Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Leerink Partners
Guggenheim
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Boundless Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | BOLD | Buy Now | Boundless Bio | $12.07 | 107.13% | Leerink Partners | Michael Cherny | → $25 | Initiates | → Outperform | Get Alert |
| 04/22/2024 | BOLD | Buy Now | Boundless Bio | $12.07 | 98.84% | Guggenheim | Yige Guo | → $24 | Initiates | → Buy | Get Alert |
| 04/22/2024 | BOLD | Buy Now | Boundless Bio | $12.07 | 65.7% | Piper Sandler | Joseph Catanzaro | → $20 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Boundless Bio (BOLD)?
The latest price target for Boundless Bio (NASDAQ: BOLD) was reported by Leerink Partners on April 22, 2024. The analyst firm set a price target for $25.00 expecting BOLD to rise to within 12 months (a possible 107.13% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Boundless Bio (BOLD)?
The latest analyst rating for Boundless Bio (NASDAQ: BOLD) was provided by Leerink Partners, and Boundless Bio initiated their outperform rating.
When was the last upgrade for Boundless Bio (BOLD)?
There is no last upgrade for Boundless Bio.
When was the last downgrade for Boundless Bio (BOLD)?
There is no last downgrade for Boundless Bio.
When is the next analyst rating going to be posted or updated for Boundless Bio (BOLD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Boundless Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Boundless Bio was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Boundless Bio (BOLD) correct?
While ratings are subjective and will change, the latest Boundless Bio (BOLD) rating was a initiated with a price target of $0.00 to $25.00. The current price Boundless Bio (BOLD) is trading at is $12.07, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.